about
The Production Processes and Biological Effects of Intravenous ImmunoglobulinAdverse event management in patients with relapsed and refractory multiple myeloma taking pomalidomide plus low-dose dexamethasone: A pooled analysis.Health-related quality of life data from a phase 3, international, randomized, open-label, multicenter study in patients with previously treated mantle cell lymphoma treated with ibrutinib versus temsirolimus.Direct measurement of lymphocyte receptor diversity.Advantageous use of lenalidomide in multiple myeloma: discussion of three case studies.Ibrutinib versus temsirolimus in patients with relapsed or refractory mantle-cell lymphoma: an international, randomised, open-label, phase 3 study.Lenalidomide is effective and safe for the treatment of patients with relapsed multiple myeloma and very severe renal impairment.Long-term survival in multiple myeloma.Broadened T-cell repertoire diversity in ivIg-treated SLE patients is also related to the individual status of regulatory T-cells.Active regulatory T-cells contribute to broadened T-cell repertoire diversity in ivIg-treated SLE patients.B cell-dependent TCR diversification.Treatment with polyclonal immunoglobulin during T-cell reconstitution promotes naive T-cell proliferation.Ibrutinib versus temsirolimus: 3-year follow-up of patients with previously treated mantle cell lymphoma from the phase 3, international, randomized, open-label RAY study.Immunoglobulin is a highly diverse self-molecule that improves cellular diversity and function during immune reconstitution.Immunoglobulin promotes the diversity and the function of T cells.Treatment with Low Doses of Polyclonal Immunoglobulin Improves B Cell Function During Immune Reconstitution in a Murine ModelPassive Serum Therapy to Immunomodulation by IVIG: A Fascinating Journey of AntibodiesEfficacy and safety of lenalidomide in relapse/refractory multiple myeloma—Real life experience of a tertiary cancer center[Monoclonal gammopathies of indetermined significance: diagnosis and clinical follow-up guidelines]Cytogenetic abnormalities in MALT lymphomas and their precursor lesions from different organs. A fluorescence in situ hybridization (FISH) studyEarly lymphocyte recovery after autologous stem cell transplantation predicts superior survival in mantle-cell lymphomaDefinition of Immunological Nonresponse to Antiretroviral Therapy: A Systematic ReviewQuantification of tumor burden in multiple myeloma by atlas-based semi-automatic segmentation of WB-DWIMultiple myeloma in elderly patients-a Portuguese multicentric real-life study
P50
Q26752540-4186839C-14EF-4EF4-9415-A7E352D74C86Q33441845-E02CC35E-C8A5-46B2-AB96-F8D6F80AC26FQ36384588-290BE602-16E6-4DAB-AD57-0D5C897ED817Q37371837-5A2265FD-96E8-42E8-9CD8-3FE0FCD3CCE4Q37975899-948783B7-C83E-4C26-8F03-3E2FD208C2C9Q38670952-42193614-C094-4AB8-95D1-D3B9607644C2Q40718791-F360B6DD-6421-498B-851F-784DBAC788C3Q43008248-97835F14-BDEA-4720-9BCB-BC61A0250BF6Q43736626-13DAB333-5EFB-4310-8989-ADDA4C4E28D9Q46090296-F8913807-21A6-44E6-9BC4-6A8FE3E9A277Q47810496-96FAE690-24F9-4BD4-8C54-2C247AABA309Q51049996-B852A7E1-55DE-4F07-9C1A-A74A0662B237Q52724560-A1808350-9028-4DC2-B197-73D603A288F3Q53607097-5CD8F6E8-2644-4262-B9B3-8808A3201530Q53616359-B0BB1D29-D272-4362-85EE-178153F4FEC1Q57640701-AAAC2D49-E89D-4E75-BD6B-14D16BCEC8CDQ58864507-CFE824A5-E4C2-4ADD-AE85-E4D7F39BC8D9Q59616731-DF45E97C-92B1-4F93-A97D-C799E0890F13Q59616734-DD022506-5E9A-41D8-A894-03D585725678Q59616740-99062D32-1CC0-4A52-A765-6F838A052AA1Q59616741-053E5FDC-CB69-4406-B00F-525091167618Q90586002-B087E484-2496-4E46-A8D2-7D0A9491B259Q92605472-6B29F2F6-5533-4F31-AC73-512F86BD8E32Q92958742-D6B2A325-8C22-4D42-A338-6B5819890FBF
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Cristina João
@ast
Cristina João
@en
Cristina João
@es
Cristina João
@nl
Cristina João
@sl
type
label
Cristina João
@ast
Cristina João
@en
Cristina João
@es
Cristina João
@nl
Cristina João
@sl
prefLabel
Cristina João
@ast
Cristina João
@en
Cristina João
@es
Cristina João
@nl
Cristina João
@sl
P106
P1153
14045450400
P21
P31
P496
0000-0002-3978-766X